Results 181 to 190 of about 1,132,441 (330)
Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer-a retrospective cohort study providing real-world survival and safety data from the United Kingdom. [PDF]
Salf J +20 more
europepmc +1 more source
The development of tag-based cooperation via a socially acquired trait
Emma Cohen, Daniel B. M. Haun
openalex +2 more sources
RFID Estimation With Blocker Tags
Xiulong Liu +6 more
semanticscholar +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Radio telemetry of butterflies: practical insights and critical tag-weight thresholds. [PDF]
Heitzler S +4 more
europepmc +1 more source
Group Collision Tracking Tree for Passive Multi-Tags RFID Systems
M. S. Yaacob +7 more
openalex +2 more sources
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Study on the Localization Technology for Giant Salamanders Using Passive UHF RFID and Incomplete D-Tr Measurement Data. [PDF]
Sun N, Lu D, Yang X, Gao H, Chen J.
europepmc +1 more source
Tagging the juvenile locus in soybean [Glycine max (L.) Merr.] with molecular markers
Carlos Alberto Cairo +6 more
openalex +2 more sources
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source

